Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8351–8400 of 18431
the following individuals were appointed to serve as executive officers of the Company: Name Position Wensheng Fan Chief Executive Officer and Director
Nils Windler Chief Financial Officer
Anthony Capone resigned as the Chief Executive Officer of DocGo Inc. (the “Company”) and from all other positions with the Company due to personal reasons.
On September 15, 2023, the Board of Directors of the Company (the “Board”) appointed Lee Bienstock, the Company’s current President and Chief Operating Officer, as the Chief Executive Officer of the Company, effective immediately.
the Board of Directors (the “Board”) of the Company had appointed Robert C. Flexon, the Company’s then current Chairman of the Board, to serve as Interim President and Chief Executive Officer, effective August 22, 2023.
The Company engaged Jade Barnwell as its Chief Financial Officer as set forth in the Current Report on Form 8-K filed August 3, 2023.
On June 16, 2023, the registrant (“Laser Photonics”), with the concurrence of its Audit Committee, discontinued its relationship with William Campbell who was serving without any employment or consulting agreement with Laser Photonics as Interim CFO.
On September 14, 2023, James W. Creamer III voluntarily resigned as the Company’s Chief Financial Officer.
On September 11, 2023, Seth Van Voorhees, Ph.D., resigned from his position as the Chief Financial Officer of the Company. His resignation will be effective as of September 30, 2023, in order to facilitate a smooth transition.
on September 13, 2023, the Company appointed Richard Narido, 45, to serve as Interim Chief Financial Officer of the Company.
The Board also appointed Geoffrey C. Gillespie as Interim Chief Financial Officer and Puja Leekha as Interim Chief Legal Officer, each effective immediately.
On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.
Also on September 11, 2023, the Board appointed Catherine M. Burzik, the current Chair of the Board, as Interim Chief Executive Officer, effectively immediately.
On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.
Effective with Mr. Colpitts’ departure, Thad Trent, who has served as Executive Vice President, Chief Financial Officer, and Treasurer of the Company since February 2021, will assume the additional role of principal accounting officer.
Effective September 12, 2023, the Board of Directors (the “Board”) of Legacy Housing Corporation (“Legacy” or the “Company”) appointed Jeff Fiedelman, age 54, as Chief Financial Officer (“CFO”).
Mr. Fiedelman replaces Ronald Arrington, who stepped down as CFO on September 11, 2023.
Mr. Xianchang Ma, previously the Chief Executive Officer, President, Chief Financial Officer and Director of the Company, passed away on August 3, 2023.
On September 13, 2023, the Board resolved to appoint Ms. Qiuping Lu as the Chief Executive Officer, President, Chief Financial Officer of the Company.
has appointed Steven Gatoff as Chief Financial Officer of the Company, effective September 14, 2023
to replace Robert G. Barbieri, who is leaving the Company to pursue other interests.
On September 13, 2023, effective immediately, Chunyi (Charlie) Hao submitted his resignation as Chief Executive Officer.
effective as of August 21, 2023 (the “Termination Date”), Josh Lehrer, M.D., the former President, Chief Executive Officer and member of the Board of Directors of Graphite Bio, Inc. (the “Company”), separated from his employment and all officer and director positions with the Company.
effective September 15, 2023, Daniel Zubeck, the Company’s Chief Financial Officer, will resign from the Company.
Michael J. Lotz, the Company’s President, will serve as interim Chief Financial Officer.
Effective concurrently with Mr. Ford’s designation as the Company’s principal accounting officer, the designation of Mr. John Collins in that capacity ended.
announced that Uneek Mehra had joined the Company as Chief Financial and Business Officer, Principal Financial Officer, Principal Accounting Officer, and Assistant Secretary of the Company.
announced that August J. Moretti will retire as Chief Financial Officer and Assistant Secretary of the Company, effective September 11, 2023.
Marc Montagner has been appointed to serve as the Executive Vice President & Chief Financial Officer of the Company (the “CFO”) to succeed Mr. Brendan Cavanagh, effective January 1, 2024.
Mr. Cavanagh, currently the Company’s Executive Vice President & Chief Financial Officer, will succeed Mr. Jeffrey Stoops as President and Chief Executive Officer, effective January 1, 2024.
Mr. Cavanagh, currently the Company’s Executive Vice President & Chief Financial Officer, will succeed Mr. Jeffrey Stoops as President and Chief Executive Officer, effective January 1, 2024.
the Board appointed Brandon L. Brown, Sr. as the Company’s Senior Vice President and Chief Financial Officer, effective as of September 27, 2023
On September 7, 2023, Mr. Salah Gamoudi notified the Board of Directors (the “Board”) of SandRidge Energy, Inc. (the “Company”) that he is resigning as the Company’s Executive Vice President and Chief Financial Officer effective September 27, 2023 (the “Resignation”), to pursue other opportunities.
The Board of Directors (the “Board”) of Madrigal Pharmaceuticals, Inc. (the “Company”) appointed Bill Sibold as the President and Chief Executive Officer of the Company, increased the Board size to nine and appointed Bill Sibold as a member of the Board, in each case effective as of 5:01 p.m. ET on September 8, 2023 (the “Start Date”).
As of the Start Date, Dr. Friedman stepped down as Chief Executive Officer but will continue to serve as a director of the Company.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Goldman Sachs BDC, Inc. (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Goldman Sachs Private Middle Market Credit LLC (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
On September 7, 2023, David Pessah notified Goldman Sachs Private Middle Market Credit II LLC (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Goldman Sachs Middle Market Lending Corp. II (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Goldman Sachs Private Credit Corp. (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Phillip Street Middle Market Lending Fund LLC (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
On September 8, 2023, effective immediately, the following officers submitted the resignation of their respective offices: Daniel Braatz as Chairman of the Board and Chief Executive Officer and Xavier Martinez as Chief Financial Officer.
On September 8, 2023, effective immediately, the following officers submitted the resignation of their respective offices: Daniel Braatz as Chairman of the Board and Chief Executive Officer and Xavier Martinez as Chief Financial Officer.
On September 13, 2023, Charlotte’s Web Holdings, Inc. (the “Company”) announced the appointment of William Morachnick, age 59, as the Company’s Chief Executive Officer effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.